KAUST researchers develop new method for more precise plant engineering #NBTintheNews www.kaust.edu.sa/en/news/kaus...

Imaging offers clearer insights to cancer #NBTintheNews via @glasgow.ac.uk www.gla.ac.uk/news/headlin...

ENVnet provides a global molecular resource of dissolved organic matter - @berkeleylab.lbl.gov @jgi.doe.gov www.nature.com/articles/s41...

The SynCell Asia Initiative outlines a strategy for developing core functional modules followed by their systems-level integration through the establishment of a centralized, AI-driven biofoundry go.nature.com/4tW9FZg rdcu.be/fugoc

Quantum computing in transition Hybrid quantum–classical computers will achieve quantum advantage in biotechnology, bridging the time until a full quantum computer becomes available www.nature.com/articles/s41...

The July issue is live nature.com/nbt/volumes/... On the cover, @ycongzhang.bsky.social @efranzosa.bsky.social @hutlab.bsky.social introduce FUGAsseM, a method that uses microbial community data to infer the functions of previously uncharacterized gene products go.nature.com/435C4lp rdcu.be/ftNUV

Frontier AI companies as biotech acquirers www.nature.com/articles/s41...

For years, the idea of targeted protein degradation stalled because PROTACs were too large and unstable for clinical use. However, in the beginning of May, @fda.gov approved the use of the first PROTAC for adults with a certain form of metastatic breast cancer go.nature.com/4x3NYt7

Educating for translation www.nature.com/articles/s41...

The June issue is live www.nature.com/nbt/volumes/... On the cover, Liu et al. present a solid tumor system that supports CAR‑T delivery and real‑time analysis of tumor–CAR‑T dynamics, evaluation of engineering strategies, and identification of druggable targets go.nature.com/3Jc62gv rdcu.be/foISS

RNA at the Bench and Bedside is back for a 5th time, covering all the latest advances in nucleic acid medicines, from clinical trials to AI methods. Organized in partnership with Ionis Pharma, Alnylam & UCSD School of Medicine. Register now! go.nature.com/4xgXqJZ

Circling back to RNA vaccines While circRNA is often framed as a more stable, longer-lasting alternative to linear mRNA, its real-world advantages remain largely theoretical, and it is unclear whether greater molecular stability will translate into meaningful clinical gains go.nature.com/3RzqxHN

Wearable ultrasound patch could help doctors spot danger signs in pregnancy earlier #NBTintheNews via @ox.ac.uk www.ox.ac.uk/news/2026-05...

Asia unveils 10-year roadmap for artificial life research #NBTintheNews qazinform.com/news/asia-un...

Research spotlight: Researchers develop mRNA strategy to turn “cold” tumors “hot” #NBTintheNews via @mgbresearch.bsky.social www.massgeneralbrigham.org/en/about/new...

While circRNA is often framed as a more stable, longer-lasting alternative to linear mRNA, its real-world advantages remain largely theoretical, and it is unclear whether greater molecular stability will translate into meaningful clinical gains go.nature.com/3RzqxHN

The May issue is live nature.com/nbt/volumes/... On the cover, Zhang et al. describe an antibody-based therapy against drug-resistant S. aureus. The antibody conjugate selectively binds to the wall teichoic acid of the bacteria and enriches calcium on the cell envelope go.nature.com/3UaGItg

As measurement resolution, depth and throughput improve in single-cell and spatial proteomics, progress is increasingly constrained not by experimental sensitivity but by the ability to integrate proteomic data across experiments, modalities and spatial contexts go.nature.com/3NHDkGP rdcu.be/fij7N

The US Supreme Court’s decision in Loper Bright, along with federal spending cuts, may limit the potential of synthetic biology to provide innovative solutions for environmental challenges, medicine and biomanufacturing go.nature.com/4cE794D rdcu.be/fikex

Progress toward a true virtual cell will depend on uniting AI’s pattern-finding power with the causal rigor of mechanistic models go.nature.com/48muYvd rdcu.be/fh599

HKUST researchers flip the CRISPR script to develop world's first DNA-guided gene editing tool for precise infectious disease diagnosis and advancing antiviral therapies #NBTintheNews hkust.edu.hk/news/hkust-r...

Advancing care with digital lungs Scientists at UHN develop digital twins of human lungs using Ex Vivo Lung Perfusion data #NBTintheNews www.uhnresearch.ca/news/5-04-20...

Establishing a commercial solution for extremely rare genetic diseases go.nature.com/4aHSIvu

Engineered dual-bacterial sensors turn chemical signals into electricity #NBTintheNews news.rice.edu/news/2026/en...

Scientists snap kinases in motion to reveal ‘invisible’ states for drug discovery www.nature.com/articles/s41... [🔓read free with login]

The April issue is live www.nature.com/nbt/volumes/... On the cover: Ishiguro et al. describe CloneSelect, which uses barcode-specific CRISPR base editing to activate a reporter gene, enabling precise isolation of individual clones from complex cell populations retrospectively go.nature.com/4ksLOMD

By integrating career programming into their funding strategies, philanthropies can serve as catalysts for change, providing resources and training that institutions may struggle to offer consistently go.nature.com/4lXKHq5 rdcu.be/fdeC8

Most of the world’s diseases have been forgotten by commercial drug development. Patient advocacy groups must look to new types of partnerships to develop therapies go.nature.com/4d8aDx3 rdcu.be/fcEmY

Minimal life by computer go.nature.com/48muYvd

For Nature Biotechnology's 30th anniversary, we asked a selection of leaders from across biotech to look at the future of the sector and make some predictions for the coming years go.nature.com/4uR7pVa rdcu.be/fbW5k